MAY KATHARINE LEHMAN: Open Payments
NPI 1073939385 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 9 payments from 8 companies in 2025. Trend: 2023 $464 · 2024 $290 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $126 |
| Amgen Inc. | 2 | $54 |
| Alnylam Pharmaceuticals Inc. | 1 | $38 |
| Smith+Nephew, Inc. | 1 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: REPATHA, AMVUTTRA, COLLAGENASE SANTYL, GORE VIABAHN VBX Balloon Expandable Endo, LEQVIO, LifeVest, FARXIGA.
Industry payments across WY — which companies pay providers there.
